CorMedix CRMD Stock-based compensation, shares issued during period (in shares)
Stock-based compensation, shares issued during period (in shares) at other companies
Other financials
Where this comes from
Reported directly by CorMedix in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod.
The official record: CorMedix’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about CorMedix's stock-based compensation, shares issued during period (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CorMedix's stock-based compensation, shares issued during period (in shares)?
- CorMedix (CRMD) reported stock-based compensation, shares issued during period (in shares) of 33.2K in Q4 2025.
- What does stock-based compensation, shares issued during period (in shares) mean?
- This metric represents the total number of equity-based instruments, such as stock options or restricted stock units, issued to employees and directors during the reporting period as part of compensation packages. It serves as a key indicator of the company's approach to talent retention and long-term incentive alignment. Investors monitor this to assess potential dilution of existing shareholders and the overall cost of human capital management.